Buy Prolia (denosumab) Injection 1 pre-filled syringe 60mg/ml Online For Sale
Prolia is a subcutaneous injection used to treat osteoporosis by inhibiting osteoclast activity and reducing bone loss. It targets RANK ligand, which stimulates osteoclasts and reduces the risk of fractures. Prolia is approved for men and postmenopausal women at high risk of fracture and for individuals with bone loss associated with cancer treatment. Clinical studies have shown that Prolia reduces the risk of vertebral, hip, and non-vertebral fractures and increases bone mineral density. It is generally well-tolerated with rare serious side effects. However, Prolia is not recommended for individuals with specific medical conditions. People should discuss the risks and benefits with their healthcare provider.
Prolia is a medicine used for the treatment of osteoporosis. Osteoporosis is a condition where the bones become weak and brittle, making them more susceptible to fractures. Prolia works by inhibiting osteoclast activity, which are cells that break down bones, leading to bone loss.
Prolia is a subcutaneous injection that is administered every six months. It is an antibody that targets RANK ligand, a protein that stimulates osteoclasts. By inhibiting RANK ligand, Prolia reduces bone loss and decreases the risk of fractures.
Prolia is approved for the treatment of osteoporosis in postmenopausal women, men with osteoporosis, and individuals who are at high risk of fracture. It has also been approved for the treatment of bone loss associated with hormone ablation in men with prostate cancer and in women with breast cancer who are undergoing treatment with aromatase inhibitors.
In clinical studies, Prolia has been shown to significantly reduce the risk of vertebral, hip, and non-vertebral fractures. In one study, Prolia reduced the risk of vertebral fractures by 68% and hip fractures by 40% in postmenopausal women with osteoporosis. Prolia has also been shown to increase bone mineral density, which is an important marker of bone health.
Prolia is generally well-tolerated, with the most common side effects including back pain, pain in the extremities, and musculoskeletal pain. In rare cases, Prolia can cause serious side effects, such as severe allergic reactions, osteonecrosis of the jaw, and atypical femoral fractures. However, the risk for these events is considered low.
People considering taking Prolia should discuss the risks and benefits with their healthcare provider. Prolia is not recommended for individuals with hypocalcemia, those who are pregnant or who may become pregnant, and those with a history of osteonecrosis of the jaw.
Prolia is an important treatment option for individuals with osteoporosis and those at high risk of fractures. It has been shown to be effective in reducing the risk of fractures and increasing bone mineral density. Prolia is generally well-tolerated, though individuals should discuss potential side effects with their healthcare provider. Overall, Prolia is a valuable tool in the prevention and treatment of osteoporosis.